Lepu Biopharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 491

Employees

  • Stock Symbol
  • 02157

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $0.40
  • (As of Monday Closing)

Lepu Biopharma General Information

Description

Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No.651, Lianheng Road
  • Minhang District
  • Shanghai, 201612
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
HKG
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No.651, Lianheng Road
  • Minhang District
  • Shanghai, 201612
  • China
+86 021

Lepu Biopharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lepu Biopharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.40 $0.39 $0.28 - $0.83 $678M 1.71B 2.62M

Lepu Biopharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 810,574 921,061 1,511,931
Revenue 28,498 31,852 2,312 0
EBITDA (10,467) 11,677 (89,037) (144,813)
Net Income (10,091) (3,123) (102,316) (156,572)
Total Assets 335,843 336,358 366,584 326,644
Total Debt 106,611 105,355 100,054 52,598
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lepu Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lepu Biopharma‘s full profile, request access.

Request a free trial

Lepu Biopharma Patents

Lepu Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023220523-A1 Anti-5t4 antibodies and uses thereof Pending 21-Feb-2022
US-20240247073-A1 Tumor antigen-dependent cd40 agonists antibodies Pending 21-Jan-2022
US-20240209109-A1 Tumor antigen-dependent cd40 agonists antibodies Pending 21-Jan-2022
US-20240287208-A1 Tumor antigen-dependent cd40 agonists antibodies Pending 21-Jan-2022
US-20240182541-A1 Antibody prodrugs with constant domains Pending 23-Aug-2021 C07K14/7051
To view Lepu Biopharma’s complete patent history, request access »

Lepu Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lepu Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lepu Biopharma‘s full profile, request access.

Request a free trial

Lepu Biopharma Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zenas BioPharma 07-May-2024 Drug Discovery
Miracogen 01-May-2020 Drug Discovery
KYM Biosciences 02-Dec-2019 Drug Discovery
HealSun Biopharm 09-Aug-2018 Biotechnology
Binhui Biopharm 03-Aug-2018 Later Stage VC Biotechnology
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Lepu Biopharma Subsidiaries (1)

Company Name Industry Location Founded
Miracogen Drug Discovery Shanghai, China
To view Lepu Biopharma’s complete subsidiaries history, request access »

Lepu Biopharma ESG

Risk Overview

Risk Rating

Updated February, 20, 2024

34.05 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,009

Rank

Percentile

Pharmaceuticals

Industry

of 909

Rank

Percentile

Pharmaceuticals

Subindustry

of 446

Rank

Percentile

To view Lepu Biopharma’s complete esg history, request access »

Lepu Biopharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Zenas BioPharma 07-May-2024 Completed
  • 15 buyers
To view Lepu Biopharma’s complete exits history, request access »

Lepu Biopharma FAQs

  • When was Lepu Biopharma founded?

    Lepu Biopharma was founded in 2018.

  • Where is Lepu Biopharma headquartered?

    Lepu Biopharma is headquartered in Shanghai, China.

  • What is the size of Lepu Biopharma?

    Lepu Biopharma has 491 total employees.

  • What industry is Lepu Biopharma in?

    Lepu Biopharma’s primary industry is Drug Discovery.

  • Is Lepu Biopharma a private or public company?

    Lepu Biopharma is a Public company.

  • What is Lepu Biopharma’s stock symbol?

    The ticker symbol for Lepu Biopharma is 02157.

  • What is the current stock price of Lepu Biopharma?

    As of 04-Nov-2024 the stock price of Lepu Biopharma is $0.40.

  • What is the current market cap of Lepu Biopharma?

    The current market capitalization of Lepu Biopharma is $678M.

  • What is Lepu Biopharma’s current revenue?

    The trailing twelve month revenue for Lepu Biopharma is $28.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »